Aanjaneya Lifecare IPO Review
Aanjaneya Lifecare IPO is yet to receive analyst coverage — analyst reports and verdicts will be updated here as and when they are published. The IPO is priced in the band of ₹228-240 per share with a minimum lot size of 25 shares (minimum investment of ₹6,000). Subscription ran from 09 May 2011 to 12 May 2011. The issue size is ₹117 crore, entirely a fresh issue. In the meantime, you can track the live GMP and subscription status for early market signals.
Researched & reviewed by
Abhishek Vohera,
Founder, IPO Guru
Last updated
Figures sourced from the RHP, BSE & NSE
Detailed review
Download our Android App to check other reviews.
Latest IPO reviews
How analysts rated the most recent mainboard issues — and, where they have listed, how the call played out.
Frequently asked
Should I apply for Aanjaneya Lifecare IPO?
Analyst coverage for Aanjaneya Lifecare IPO has not been published yet. Verdicts will be added here as analyst reports come in. IPO Guru does not make buy or sell recommendations. Read the individual analyst reports and consult a SEBI-registered advisor before investing.
What does the score of N/A mean for Aanjaneya Lifecare IPO?
Analyst scoring is not yet available for Aanjaneya Lifecare IPO. The score will be updated once analyst reports start coming in.
What was the actual listing price of Aanjaneya Lifecare IPO?
Aanjaneya Lifecare IPO listed on May 27, 2011 at ₹218, against the issue price of ₹234 — a loss of -6.84% (₹16 per share). View the full GMP history page for day-wise pre-listing trends.
What is the price band and lot size of Aanjaneya Lifecare IPO?
Aanjaneya Lifecare IPO was priced at ₹228-240 per share. The minimum lot size is 25 shares, making the minimum investment approximately ₹6,000 at the upper end of the price band. Subscription ran from 09 May 2011 to 12 May 2011.
Explore Aanjaneya Lifecare IPO further
Analyst views are one input. Read them alongside the demand, the grey market and the filings before you decide.
It has listed — go back to the fundamentals.
Live grey market premium, Kostak and Subject to Sauda, with the day-wise trend.
Category-wise demand from QIB, NII and retail investors, updated through the day.
Check with your PAN whether shares were credited to your demat account.
A verdict is an opinion, not a guarantee.
IPO Guru collects analyst views, GMP, subscription and allotment for every Mainboard and SME issue. Weigh them together — and against the offer document — before you apply.
Disclaimer: Grey Market Premium (GMP) is for information purposes and is not a guarantee of listing price. Always consult your financial advisor before investing.
